Sources | Names Used |
---|---|
CTRPv2 | BRD-A02303741:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-A02303741:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RP3-403A15.5 | CTRPv2 | pan-cancer | AAC | 0.29 | 5e-12 |
mRNA | SOX4 | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-12 |
mRNA | SNAP25 | CTRPv2 | pan-cancer | AAC | 0.26 | 7e-12 |
mRNA | ZNF616 | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-12 |
mRNA | ZNF43 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-11 |
mRNA | ZNF253 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-11 |
mRNA | PRR36 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-11 |
mRNA | FAM57B | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-11 |
mRNA | SMIM17 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-11 |
mRNA | MYT1L | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-11 |